Socio-economic disparity, access to care and patient-relevant outcomes after kidney allograft failure.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
Nov 2021
Historique:
revised: 16 06 2021
received: 17 11 2020
accepted: 11 07 2021
pubmed: 3 8 2021
medline: 15 12 2021
entrez: 2 8 2021
Statut: ppublish

Résumé

Social disparity is a major impediment to optimal health outcomes after kidney transplantation. In this study, we aimed to define the association between socio-economic status (SES) disparities and patient-relevant outcomes after kidney allograft failure. Using data from the Australia and New Zealand Dialysis and Transplant registry, we included patients with failed first-kidney allografts in Australia between 2005 and 2017. The association between residential postcode-derived SES in quintiles (quintile 1-most disadvantaged areas, quintile 5-most advantaged areas) with uptake of home dialysis (peritoneal or home haemodialysis) within the first 12-months post-allograft failure, repeat transplantation and death on dialysis were examined using competing-risk analysis. Of 2175 patients who had experienced first allograft failure, 417(19%) and 505(23%) patients were of SES quintiles 1 and 5, respectively. Compared to patients of quintile 5, quintile 1 patients were less likely to receive repeat transplants (adjusted subdistributional hazard ratio [SHR] 0.70,95%CI 0.55-0.89) and were more likely to die on dialysis (1.37 [1.04-1.81]), but there was no association with the uptake of home dialysis (1.02 [0.77-1.35]). Low SES may have a negative effect on outcomes post-allograft failure and further research is required into how best to mitigate this. However, small-scale variation within SES cannot be accounted for in this study.

Identifiants

pubmed: 34339557
doi: 10.1111/tri.14002
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2329-2340

Subventions

Organisme : Wellcome Trust
ID : 102538
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102538
Pays : United Kingdom

Informations de copyright

© 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Références

Johns TS, Estrella MM, Crews DC, et al. Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients. J Am Soc Nephrol 2014; 25: 2649.
Kimmel PL, Fwu CW, Eggers PW. Segregation, income disparities, and survival in hemodialysis patients. J Am Soc Nephrol 2013; 24: 293.
Goldfarb-Rumyantzev AS, Koford JK, Baird BC, et al. Role of Socioeconomic Status in Kidney Transplant Outcome. Clin J Am Soc Nephrol 2006; 1: 313.
Chapman JR. Compliance: the patient, the doctor, and the medication? Transplantation 2004; 77: 782.
Petersen E, Baird BC, Barenbaum LL, et al. The impact of employment status on recipient and renal allograft survival. Clin Transplant 2008; 22: 428.
Coemans M, Susal C, Dohler B, et al. Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015. Kidney Int 2018; 94: 964.
Ojo A, Wolfe RA, Agodoa LY, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 1998; 66: 1651.
Chan MR, Oza-Gajera B, Chapla K, et al. Initial vascular access type in patients with a failed renal transplant. Clin J Am Soc Nephrol 2014; 9: 1225.
Johnston O, Zalunardo N, Rose C, Gill JS. Prevention of sepsis during the transition to dialysis may improve the survival of transplant failure patients. J Am Soc Nephrol 2007; 18: 1331.
Perl J, Hasan O, Bargman JM, et al. Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol 2011; 6: 582.
Girerd S, Girerd N, Duarte K, et al. Preemptive second kidney transplantation is associated with better graft survival compared with non-preemptive second transplantation: a multicenter French 2000-2014 cohort study. Transplant Int 2018; 31: 408.
Jay CL, Dean PG, Helmick RA, Stegall MD. Reassessing preemptive kidney transplantation in the United States: Are we making progress? Transplantation 2016; 100: 1120.
Krishnasamy R, Gray NA. Low socio-economic status adversely effects dialysis survival in Australia. Nephrology 2018; 23: 453.
Tao S, Zeng X, Liu J, Fu P. Socioeconomic status and mortality among dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol 2019; 51: 509.
Axelrod DA, Dzebisashvili N, Schnitzler MA, et al. The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clin J Am Soc Nephrol 2010; 5: 2276.
Grace BS, Clayton PA, Gray NA, McDonald SP. Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol 2014; 9: 929.
Taylor DM, Fraser SDS, Bradley JA, et al. A systematic review of the prevalence and associations of limited health literacy in CKD. Clin J Am Soc Nephrol 2017; 12: 1070.
Australia Bureau of Statistics. Technical Paper Socio-Economic Indexes for areas (SEIFA). 2016.
Australia Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2016.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496.
Shen JI, Chen L, Vangala S, et al. Socioeconomic factors and racial and ethnic differences in the initiation of home dialysis. Kidney Med 2020; 2: 105.
Prakash S, Perzynski AT, Austin PC, et al. Neighborhood socioeconomic status and barriers to peritoneal dialysis: a mixed methods study. Clin J Am Soc Nephrol 2013; 8: 1741.
Grace BS, Clayton PA, Cass A, McDonald SP. Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int 2013; 83: 138.
Francis A, Didsbury M, Lim WH, et al. The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children. Pediatric nephrology (Berlin, Germany) 2016; 31: 1011.
Gaylin DS, Held PJ, Port FK, et al. The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 1993; 269: 603.
Patzer RE, Perryman JP, Schrager JD, et al. The role of race and poverty on steps to kidney transplantation in the Southeastern United States. Am J Transplant 2012; 12: 358.
Khanal N, Lawton PD, Cass A, McDonald SP. Disparity of access to kidney transplantation by Indigenous and non-Indigenous Australians. Med J Aust 2018; 209: 261.
Australia and New Zealand Organ Donation Registry. 2020 Annual Report, Section 5: Deceased Donor Kidney Donation. Adelaide, Australia, 2020.
Moist LM, Bragg-Gresham JL, Pisoni RL, et al. Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008; 51: 641.
Lim WH, Boudville N, McDonald SP, Gorham G, Johnson DW, Jose M. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant 2011; 26: 3366.
Rucker D, Hemmelgarn BR, Lin M, et al. Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int 2011; 79: 210.
Xu R, Han QF, Zhu TY, et al. Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort study. PLoS One 2012; 7: e50766.
Ward FL, O'Kelly P, Donohue F, et al. The influence of socioeconomic status on patient survival on chronic dialysis. Hemodial Int 2015; 19: 601.
Kabani R, Quinn RR, Palmer S, et al. Risk of death following kidney allograft failure: a systematic review and meta-analysis of cohort studies. Nephrol Dialysis Transplant 2014; 29: 1778.
Lim WH, Wong G, Pilmore HL, McDonald SP, Chadban SJ. Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study. The Lancet Diab Endocrinol 2017; 5: 26.
Cherukuri A, Bhandari S. Analysis of risk factors for mortality of incident patients commencing dialysis in East Yorkshire, UK. QJM 2010; 103: 41.
Turrell G, Mathers C. Socioeconomic inequalities in all-cause and specific-cause mortality in Australia: 1985-1987 and 1995-1997. Int J Epidemiol 2001; 30: 231.
Draper G, Turrell G, Oldenburg B. Health Inequalities in Australia: Mortality. Canberra: Queensland University of Technology and the Australian Institute of Health and Welfare, 2004.
Tang W, Grace B, McDonald SP, et al. Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients. Perit Dial Int 2015; 35: 450.
Chan S, Cho Y, Koh YH, et al. Association of socio-economic position with technique failure and mortality in Australian non-indigenous peritoneal dialysis patients. Perit Dial Int 2017; 37: 397.
Sypek MP, Clayton PA, Lim W, et al. Access to waitlisting for deceased donor kidney transplantation in Australia. Nephrology 2019; 24: 758.

Auteurs

Yun Hui Sheryl Wong (YHS)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.

Germaine Wong (G)

University of Sydney, Sydney, NSW, Australia.
Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Department of Renal Medicine and National Pancreas Transplant Unit, Westmead Hospital, Sydney, NSW, Australia.

David W Johnson (DW)

Department of Nephrology, Princess Alexandra Hospital, Queensland, Australia.
University of Queensland, Queensland, Qld, Australia.
Translational Research Institute, Brisbane, Qld, Australia.

Stephen McDonald (S)

South Australian Health and Medical Research Institute, ANZDATA Registry, Adelaide, SA, Australia.
University of Adelaide, Adelaide, SA, Australia.
Royal Adelaide Hospital, Adelaide, SA, Australia.

Philip Clayton (P)

South Australian Health and Medical Research Institute, ANZDATA Registry, Adelaide, SA, Australia.
University of Adelaide, Adelaide, SA, Australia.
Royal Adelaide Hospital, Adelaide, SA, Australia.

Neil Boudville (N)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Medical School, University of Western Australia, Perth, WA, Australia.

Andrea K Viecelli (AK)

Department of Nephrology, Princess Alexandra Hospital, Queensland, Australia.
University of Queensland, Queensland, Qld, Australia.

Charmaine Lok (C)

Division of Nephrology, Department of Medicine, University Health Network-Toronto General Hospital, Toronto, ON, Canada.
The University of Toronto, Toronto, ON, Canada.

Helen Pilmore (H)

Department of Renal Medicine, Auckland City Hospital, Auckland, New Zealand.
Department of Medicine, Auckland University, Auckland, New Zealand.

Carmel Hawley (C)

Department of Nephrology, Princess Alexandra Hospital, Queensland, Australia.
University of Queensland, Queensland, Qld, Australia.
Translational Research Institute, Brisbane, Qld, Australia.

Matthew A Roberts (MA)

Eastern Health Clinical School, Monash University, Melbourne, Vic, Australia.

Rachael Walker (R)

Eastern Institute of Technology, Napier, New Zealand.

Esther Ooi (E)

Medical School, University of Western Australia, Perth, WA, Australia.
School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.

Kevan R Polkinghorne (KR)

Department of Nephrology, Monash Medical Centre, Melbourne, Vic., Australia.
Department of Medicine, Monash University, Melbourne, Vic., Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia.

Wai H Lim (WH)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Medical School, University of Western Australia, Perth, WA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH